Sarepta Therapeutics (SRPT) Shares Outstanding (Diluted Average) (2010 - 2025)

Sarepta Therapeutics has reported Shares Outstanding (Diluted Average) for 9 years, with the latest figure at $100.1 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) fell 7.19% year-over-year to $100.1 million; the trailing twelve-month figure through Dec 2025 stood at $100.1 million (down 7.19% YoY), and the FY2025 full-year result was $100.1 million, down 7.19% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2025 stood at $100.1 million, up from $98.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $107.9 million in Q4 2024, with the low at $88.6 million in Q3 2023.
• Average Shares Outstanding (Diluted Average) over 3 years is $98.0 million, with a median of $99.1 million recorded in 2024.
• Year-over-year, Shares Outstanding (Diluted Average) gained 16.75% in 2024 and dropped 7.19% in 2025.
• Tracing SRPT's Shares Outstanding (Diluted Average) over 3 years: stood at $92.4 million in 2023, then gained by 16.75% to $107.9 million in 2024, then slipped by 7.19% to $100.1 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $100.1 million (Q4 2025), $98.5 million (Q3 2025), and $106.6 million (Q2 2025), per Business Quant data.

Peer Comparison